Greenwich LifeSciences dismisses MaloneBailey, engages RBSM as new auditor
Greenwich LifeSciences dismissed MaloneBailey LLP as its independent registered public accounting firm and engaged RBSM LLP to audit its financial statements for the year ended December 31, 2023. The filing states that MaloneBailey's reports for 2021 and 2022 contained no adverse opinion, disclaimer, or qualification, but notes material weaknesses in internal control over financial reporting disclosed in prior filings. The change is administrative in nature, though the disclosed material weaknesses are relevant to shareholders.
- Audit committee approved the dismissal of MaloneBailey LLP and the engagement of RBSM LLP on February 14, 2024
- MaloneBailey was informed of its dismissal on February 15, 2024, effective immediately
- MaloneBailey's reports for 2021 and 2022 had no adverse opinion, disclaimer, or qualification
- Material weaknesses in internal control were disclosed in the 2022 and 2021 Form 10-K filings and in 2023 Form 10-Q filings; no disagreements with MaloneBailey are reported